Implantation of a duodenal–jejunal bypass liner for managing type 2 diabetes

Current evidence on the safety and efficacy of implantation of a duodenal–jejunal bypass liner for managing type 2 diabetes is limited in quality and quantity. Therefore, the procedure should only be used in the context of research.

Further research should give details of patient selection, including information about use of the procedure in patients with different levels of body mass index (BMI). The research should provide information on complications; reasons for early removal of the device; medication used for treating type 2 diabetes, both when the device is in place and after its removal; and control of type 2 diabetes after device removal. NICE may update the guidance on publication of further evidence.